TANG KEVIN C 4
4 · Rain Oncology Inc. · Filed Dec 18, 2023
Insider Transaction Report
Form 4
TANG KEVIN C
10% Owner
Transactions
- Sale
Common Stock
2023-12-18$1.21/sh−40,132$48,560→ 3,850,513 total(indirect: By LP) - Sale
Common Stock
2023-12-15$1.20/sh−109,435$131,322→ 3,890,645 total(indirect: By LP) - Sale
Common Stock
2023-12-14$1.21/sh−24,406$29,531→ 4,000,080 total(indirect: By LP)
Footnotes (4)
- [F1]The prices reported are weighted-average prices. These shares were sold in multiple transactions at prices ranging from $1.20 to $1.22. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares sold at each price within the ranges set forth in Footnotes 1, 3 and 4.
- [F2]The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP.
- [F3]These shares were sold in multiple transactions ranging from $1.20 to $1.22.
- [F4]These shares were sold in multiple transactions ranging from $1.20 to $1.24.